4D Molecular Therapeutics (FDMT) PT Lowered to $33 at Goldman Sachs

May 8, 2026 6:43 AM

Goldman Sachs analyst Salveen Richter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found